For patients with diabetes who also have obesity or elevated cardiovascular risk, GLP-1 therapy may offer an added advantage rather than a standalone solution
This is one of the most common questions I hear in the office
Although advertisements promote the drug as safe and effective, with few long-term side effects, there have been rising concerns over long-term gastrointestinal issues linked to the medications, and a number of former users are now investigating potential Ozempic lawsuits and Wegovy lawsuits, each raising similar claims that they developed painful and debilitating stomach problems, which could have been avoided if false and misleading information had not been provided for users and the medical community
Although initially approved for adults with type 2 diabetes, Ozempic has demonstrated additional benefits in weight loss and reducing cardiovascular risks
In clinical trials, semaglutide reduced CRP, a protein the liver releases when the body is in a state of chronic inflammatory stress, by 4050%